WORLDSymposium 2019 Satellite Symposia
16 Satellite symposia were held from Monday, February 4, 2019 to Thursday, February 7, 2019. Click here for the full schedule.
16 Satellite symposia were held from Monday, February 4, 2019 to Thursday, February 7, 2019. Click here for the full schedule.
WORLDSymposium 2019 attracted over 35 Exhibitors offering a highly interactive forum for discussion of lysosomal diseases with international researchers and health care practitioners. View Exhibitor and Patient Advocate list.
Following the presentation of the Roscoe O. Brady Award for Innovation and Accomplishment in lysosomal disease research, presentations in the morning and afternoon sessions discussed innovations in technology and how they can be applied to early diagnosis for lysosomal conditions, progress in gene therapy, and exploitation of differences at the cellular level that may indicate early disease state. View full program.
For the seventh consecutive year, WORLDSymposium began with Emerging Trends in Lysosomal Biology & Lysosomal Diseases: State-of-the-art for Experts on Monday, February 4, 2019. See agenda and faculty.
WORLDSymposium was pleased to announce the 10 recipients of the 2019 Young Investigator Awards on Monday, February 4, 2019. Click to view award recipients.
Danilo A. Tagle, PhD, MS received the 2019 Roscoe O. Brady Award for Innovation and Accomplishment. Danilo A. Tagle, PhD, MS, is associate director for special initiatives at NCATS. He also recently served as acting director of the NCATS Office of Grants Management and Scientific Review and currently serves as executive secretary to the NCATS Advisory Council and Cures Acceleration Network Review Board. More details.
In 2019, over 440 scientific abstracts were presented at two separate poster sessions beginning on Tuesday, February 5, 2019, and remained open throughout the rest of the conference. View Poster List.
WORLDSymposium 2022 Patient Advocate Leader (PAL) Award was received by Mark Dant on Wednesday, February 6, 2019. Mark Dant is the Chairman of the Board of the Washington DC-based EveryLife Foundation for Rare Diseases, a science-based advocacy organization dedicated to accelerating biotech innovations for rare disease treatments through science-driven public policy. More details.
Chester B. Whitley, PhD, MD Delivered Keynote Address on Wednesday, February 12, 2019. Dr. Whitley is a tenured Professor in the Department of Pediatrics, the Department of Experimental and Clinical Pharmacology, and Director of the Advanced Therapies Program at the University of Minnesota. Read speaker bios.